NSB.AX · NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
Australia · RS rating 20 · As of 2026-10-14
| Price | 0.06 AUD |
|---|---|
| 1-day change | -5.1% |
| RS rating (overall / 1M / 3M / 12M) | 20 / 46 / 41 / 14 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 17 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +66.1% |
| Market cap (USD) | $15.7M |